Arvinas, Inc.
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera…
Biotechnology
US, New Haven [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Arvinas, Inc. has no acquisition track records yet.
M&A Deals · History
Arvinas, Inc. has no acquisition track records yet.